Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Angiopoietin-1 (ANGPT1) is a secreted glycoprotein that plays a crucial role in vascular development, angiogenesis, and the maintenance of blood vessel stability and integrity. It primarily signals through the Tie2 receptor on endothelial cells, activating pathways that promote cell survival, inhibit apoptosis, and regulate vascular permeability and inflammation. While ANGPT1 shows promise as a therapeutic target for diseases involving abnormal vascular function, careful consideration must be given to potential off-target effects such as pathological neovascularization.
ANGPT1 binds to its receptor, Tie2, leading to Tie2 phosphorylation and activation of downstream signaling pathways such as PI3K/Akt. This promotes cell survival and vessel stabilization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiopoietin-1 (ANGPT1).